SLU-PP-332 – 500 MCG
$ 79.00 - or subscribe and save up to 8%
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an “exercise mimetic.” It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance. Each tablet contains a precisely measured 500 mcg dose for accurate, reproducible in vitro and in vivo research applications.
| Quantity | Price | Discount |
|---|---|---|
| 3-5 | $ 75.84 | 4% |
| 6-8 | $ 72.68 | 8% |
| 10-15 | $ 70.31 | 11% |
| 16+ | $ 79.00 | $ 0.00 |
Description
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an “exercise mimetic.” It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance. Each tablet contains a precisely measured 500 mcg dose for accurate, reproducible in vitro and in vivo research applications.
Tamper-evident container · Certificate of Analysis available on request · ≥99% HPLC-verified purity.
For laboratory and research use only. Not for human consumption, veterinary use, or medical applications. Must be 21+ to purchase.
You may also like
5-Amino-1MQ — NNMT Inhibitor | Research Grade
$ 45.99 - or subscribe and save up to 10%
BPC-157 Peptide — Body Protection Compound | Research Grade
$ 85.99 - or subscribe
CJC-1295 ( no DAC) + IPAMORELIN
Price range: $ 85.00 through $ 115.00 - or subscribe
